Puma Biotechnology Inc (PBYI)
2.985
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 14, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Market Cap: 146.40M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 145.91M |
| November 12, 2024 | 157.44M |
| November 11, 2024 | 161.85M |
| November 08, 2024 | 141.25M |
| November 07, 2024 | 148.61M |
| November 06, 2024 | 150.08M |
| November 05, 2024 | 145.18M |
| November 04, 2024 | 144.69M |
| November 01, 2024 | 144.69M |
| October 31, 2024 | 139.78M |
| October 30, 2024 | 139.29M |
| October 29, 2024 | 136.84M |
| October 28, 2024 | 138.80M |
| October 25, 2024 | 144.69M |
| October 24, 2024 | 137.33M |
| October 23, 2024 | 137.82M |
| October 22, 2024 | 139.29M |
| October 21, 2024 | 137.82M |
| October 18, 2024 | 141.25M |
| October 17, 2024 | 138.80M |
| October 16, 2024 | 141.25M |
| October 15, 2024 | 139.78M |
| October 14, 2024 | 139.78M |
| October 11, 2024 | 139.78M |
| October 10, 2024 | 132.92M |
| Date | Value |
|---|---|
| October 09, 2024 | 129.97M |
| October 08, 2024 | 128.50M |
| October 07, 2024 | 130.46M |
| October 04, 2024 | 129.97M |
| October 03, 2024 | 123.60M |
| October 02, 2024 | 120.65M |
| October 01, 2024 | 127.52M |
| September 30, 2024 | 125.07M |
| September 27, 2024 | 126.54M |
| September 26, 2024 | 125.56M |
| September 25, 2024 | 125.07M |
| September 24, 2024 | 125.07M |
| September 23, 2024 | 125.07M |
| September 20, 2024 | 127.52M |
| September 19, 2024 | 125.56M |
| September 18, 2024 | 122.62M |
| September 17, 2024 | 127.52M |
| September 16, 2024 | 123.60M |
| September 13, 2024 | 124.09M |
| September 12, 2024 | 123.11M |
| September 11, 2024 | 122.62M |
| September 10, 2024 | 117.22M |
| September 09, 2024 | 113.79M |
| September 06, 2024 | 110.36M |
| September 05, 2024 | 112.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
73.76M
Minimum
May 11 2022
570.95M
Maximum
Feb 05 2020
247.09M
Average
205.11M
Median
Market Cap Benchmarks
| Pfizer Inc | 147.43B |
| NovaBay Pharmaceuticals Inc | 3.555M |
| Palatin Technologies Inc | 20.92M |
| iBio Inc | 18.83M |
| Theriva Biologics Inc | 1.372M |
Market Cap Related Metrics
| PE Ratio | 6.351 |
| PS Ratio | 0.5934 |
| PEG Ratio | 0.0130 |
| Price to Book Value | 2.061 |
| Price to Free Cash Flow | 4.291 |
| Price | 2.985 |
| Earnings Yield | 15.75% |
| PEGY Ratio | 0.0130 |
| Operating PE Ratio | 4.461 |
| Normalized PE Ratio | 6.351 |